Accepted for/Published in: JMIR Biomedical Engineering
Date Submitted: May 29, 2026
Date Accepted: Oct 27, 2026
Average Acceleration as a Measure of Physical Activity Across Sensor Locations in Participants with Heart Failure, Chronic Obstructive Pulmonary Disease and Healthy Volunteers: Secondary Analysis
ABSTRACT
Background:
Average acceleration derived from wearable sensors offers a simple, continuous measure of physical activity and mobility that may overcome the limitations of complex accelerometer algorithms or site-based assessments in clinical trials. However, evidence supporting the use of average acceleration in patients with heart failure (HF) and/or chronic obstructive pulmonary disease (COPD) remains limited.
Objective:
To evaluate how average acceleration can be used to assess walking-related outcomes in both laboratory and free-living settings, and to assess the influence of sensor location on these measurements in participants with HF or COPD, and healthy volunteers.
Methods:
Using data from the Mobilise-D Technical Validation Study, including structured, laboratory-based tasks and free-living assessments using sensors placed on the foot, lower back and wrist, we analyzed average acceleration metrics computed as Euclidean norm minus one (ENMO), ENMO > 0 and Euclidean norm (EN) from band-pass filtered triaxial acceleration (0.29–10 Hz, 4th order Butterworth). During walking bouts, average acceleration was independently correlated with walking speed and cadence for each sensor location and cohort (HF, COPD, healthy adults); sensor-location effects and cohort-specific sensitivity were evaluated. Linear mixed-effects models included participants as random intercepts, and walking speed as a fixed effect and as a random effect.
Results:
Average acceleration correlated strongly with walking speed during straight walking laboratory tasks across all sensor locations; foot sensors showed the strongest association, followed by lower back, then wrist. In complex walking tasks and free-living walking bouts, correlations decreased, and location effects were more pronounced. Across cohorts during free living, filtered EN r2 ranged 0.711–0.818, 0.439–0.673 and 0.067–0.146, for the foot, lower back and wrist, respectively. Correlations for wrist data improved only during free-living sustained walking bouts (> 10 s), although these associations were less strong than those for foot and lower back. The linear correlation was marginally stronger in ENMO > 0 than filtered EN, but filtered EN preserved more signal by mitigating the influence of gravity and noise. Linear mixed-effects models showed that variance can be largely attributed to stable participant-specific differences.
Conclusions:
Average acceleration can be used to capture walking-related activity across adults with HF or COPD, and in healthy adults when using appropriate sensor placement. For speed or cadence-related outcomes, foot placement is preferred, lower back is acceptable and wrist placement is challenging, especially in free-living settings. We recommend that trials employ standardized reporting of sensor location, filtering parameters and walking-bout definitions, and that they prioritize foot or lower-back placement for walking-related endpoints.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.